Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Peptide Tyrosine-Tyrosine (PYY) receptor family primarily refers to the neuropeptide Y (NPY) receptor family, which includes Y1, Y2, Y4, and Y5 receptor subtypes. These are G-protein-coupled receptors that bind PYY, a gut-derived hormone involved in appetite regulation. PYY3-36 is the predominant circulating form and primarily binds to the Y2 receptor, suppressing appetite and modulating gastrointestinal motility. Modulators targeting these receptors, especially the Y2 receptor, are under investigation for obesity treatment.
Agonists or antagonists of NPY receptor subtypes (Y1, Y2, Y4, Y5). Primarily Y2 receptor modulation to regulate appetite and gastrointestinal function.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptide Tyrosine-Tyrosine Receptor Family (PYY Receptor Family).